75 results on '"Tursz A"'
Search Results
2. Hurdles on the road to personalized medicine.
3. Epidemiological data on shaken baby syndrome in France using judicial sources.
4. Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients.
5. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
6. A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences.
7. Les néonaticides devant la justice : le reflet d’une ambivalence face à ces crimes ?
8. A population-based survey of neonaticides using judicial data.
9. Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα.
10. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S
11. FMC en cancérologie. Le point de vue de l’EFEC.
12. Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome.
13. A novel dendritic cell subset involved in tumor immunosurveillance.
14. Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1 146 patients with early breast cancer.
15. Full kringles of plasminogen (aa 1-566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice.
16. Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients.
17. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.
18. Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers.
19. Sequelae after unintentional injuries to children: an exploratory study.
20. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line.
21. Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells.
22. High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
23. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo.
24. Low natural killer cell activity in patients with malignant lymphoma.
25. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma.
26. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas.
27. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
28. Expression of the c- fgr related transcripts in epstein-barr virus-associated malignancies.
29. Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus.
30. Characterization of neural cell adhesion molecules (NCAM) expressed by ewing and neuroblastoma cell lines.
31. Induction of cell differentiation in burkitt lymphoma lines. BLA: A glycolipid marker of B-cell differentiation.
32. Expression of the bla antigen, defined by the monoclonal 38.13 antibody, on burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other b-cell lymphomas and leukemias.
33. A monoclonal antibody with anti-burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
34. Chemical Signals of Cellular Interactions.
35. Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynx.
36. Does malignant small round cell tumor of the thoracopulmonary region (Askin tumor) constitute a clinicopathologic entity? An analysis of 30 cases with immunohistochemical and electron-microscopic support treated at the Institute Gustave Roussy.
37. A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma.
38. Phenotypic characterization of Ewing sarcoma cell lines with monoclonal antibodies.
39. First-Line Vinorelbine-Mitoxantrone Combination in Metastatic Breast Cancer Patients Relapsing after an Adjuvant Anthracycline Regimen: Results of a Phase II Study.
40. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.
41. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
42. Differential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt's lymphoma cell lines.
43. The development of human tumor-cell resistance to TNF-α does not confer resistance to cytokine-induced cellular cytotoxic mechanisms.
44. Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in epstein-barr-virus-positive nasopharyngeal carcinoma cells.
45. CD77: an antigen of germinal center B cells entering apoptosis.
46. Comparison of interleukin 2 and 12-O-tetradecanoyl-phorbol 13-acetate as signals for protein kinase C activation in purified human T lymphocytes.
47. A 93-kDa glycoprotein expressed on human cultured monocytes and dendritic reticulum cells defined by an anti-K562 monoclonal antibody.
48. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
49. Target structure for natural killer cells: evidence against a unique role for transferrin receptor.
50. Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.